October 7-10, 2021
Virtual Meeting

Scientific Committee Cochairs

Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
James L. Gulley, National Cancer Institute, Bethesda, Maryland
Ruth Plummer, Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom

Organizing Committee Cochairs

Antoni Ribas, University of California Los Angeles (UCLA), Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, California
James H. Doroshow, National Cancer Institute, Bethesda, Maryland
Denis A. Lacombe, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

Hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, the 2021 Molecular Targets and Cancer Therapeutics conference will take place as a virtual event due to the continued impact of COVID-19 on travel and in-person scientific meetings. The conference has historically attracted 1,500-2,500 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, the impact of new discoveries in cellular and molecular biology, and early clinical trials.

supporters

Janssen
Novartis

PROFESSIONAL EDUCATIONAL GRANTS

Incyte
Ipsen
Lilly
Merck
Pfizer

Poster supporters

#Targets21